The popular weight loss drugs have also been found to reduce other risks, including the risk of death from COVID-19.

More than a quarter of us have learned all we know about weight-loss jabs through social media, so GP Dr Bryony Henderson has helped clear up the myths and misunderstandings ...

Biotech companies are racing to find Ozempic 2.0, hoping for a slice of a multi-billion-dollar industry. A few stand-out ...

The death of a Scottish nurse as a result of complications after taking the drug Mounjaro for weight loss has highlighted the potential dangers ...

A new study has found that the groundbreaking new class of weight loss drugs may not only be good at treating diabetes, but ...

Research shows that 1 in 8 adults in the US has used one of the popular GLP-1 medications, most of them trying to manage ...

The best online providers offer strong support services to help you succeed in your GLP-1 weight loss journey.

A recent study conducted in Sweden found that GLP-1 agonists such as Ozempic and Wegovy may help reduce alcohol consumption and related harms in individuals diagnosed with alcohol use disorder. Here ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has reported that 68 people have been admitted to hospital ...

Scholars discuss the regulatory landscape surrounding GLP-1 drugs and dietary supplements.

The majority of strokes could be prevented, according to new guidelines aimed at helping people and their doctors do just ...

Researchers studied the trends in alcohol use after the COVID-19 pandemic, comparing data from 2018, 2020 and 2022.